Congratulations to David Weiss, PhD, co-PI of the Heteroresistance AST team, currently participating in the Biolocity Launch program. David Weiss, is the director of Emory’s Antibiotic Resistance Center and his team received a five-year $11 million grant from NIAID to continue their work in studying heteroresistance to treat bacterial infections.
Page 6 of 14
Congratulations to Biolocity graduate company, Sanquina, on their newly announced collaboration with AstraZeneca on a study to develop a custom version of AnemoCheck Mobile, a smartphone application that provides noninvasive and equipment-free hemoglobin levels for patients with anemia of chronic kidney disease. Learn more about the collaboration here.
The AnemoCheck/Sanguina Team, Dr. Wilbur Lam and Erika Tyburski, received support from the Biolocity program (then the Coulter Translational Program) in 2016. We are excited for their continued success and this new collaboration with AstraZeneca!
“Biolocity enabled us to receive an FDA 510(k) clearance on our first generation product. We couldn’t have done it without the support of Biolocity.”
– Erika Tyburski, AnemoCheck
The Biolocity team is grateful for the generosity of John & Rosemary Brown in supporting our work to accelerate innovation. Their gift will help expand our support of entrepreneurs at Emory and Georgia Tech who are developing early-stage biomedical technologies that positively impact patient health.